Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
- 1295.115
- +9.085+0.71%
Santa Clause Came and Went Without Bringing Gifts | Weekly Buzz
Friday? More Like Grinch Day | Wall Street Today
Santa Claus Came Without Rallying the Troops | Live Stock
Oracle, Snowflake Next up Among Top AI Software Plays in 2025: Wedbush
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
9 Analysts Have This To Say About Sangamo Therapeutics
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Glaukos To Rally Around 17%? Here Are 6 Top Analyst Forecasts For Tuesday
Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Market-Moving News for December 31st
Bluebird Bio Analyst Ratings
Sangamo Therapeutics Analyst Ratings
Why Cemtrex Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
CompoSecure, Cemtrex And 3 Stocks To Watch Heading Into Tuesday
Sangamo Says Collaboration, License Agreement With Pfizer On Giroctocogene Fitelparvovec Will Terminate Effective April 21, 2025; Plans To Explore All Options To Commercialize The Asset, Including Seeking Potential New Partner
Market Falling Monday, With Few Santa Clause 'Rally' Days Left | Live Stock
Weekly Buzz: So far, Santa is Letting us Down
Friday Market Pulls Back, Led by Mag Seven Decline | Live Stock
10 Health Care Stocks With Whale Alerts In Today's Session
Here's How Much You Would Have Made Owning Agilent Technologies Stock In The Last 10 Years